SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 15, 2013
NEUROMAMA, LTD.
(Exact name of registrant as specified in charter)
| Nevada | 333-180750 | 98-0706304 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 182/1 Krasniy Prospekt, Suite # 704, Novosibirsk, Russia | 630049 |
| (Address of principal executive offices) | (Zip Code) |
+73833542023
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01. Other Events.
On November 15, 2013, Alexander Vikoulov, the Chief Financial Officer, Secretary and a Director of Neuromama, Ltd. (the “Company”) requested that the Company cancel 2,535,000,001 common shares of the Company that he owns in his own name. As a result, Mr. Vikoulov now owns 90,100,000 common shares of the Company. As of November 15, 2013 there are 630,100,000 common shares of the Company issued and outstanding.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| NEUROMAMA, LTD. |
| |
|
|
|
|
|
| Date: November 25, 2013 | By: | /s/ Igor Weselovsky |
|
|
|
| Igor Weselovsky, C.E.O. & Director |
|